Anesthesia, TIVA, Balanced Anesthesia, NK Cell
Colorectal Cancer
About this trial
This is an interventional prevention trial for Colorectal Cancer
Eligibility Criteria
Inclusion Criteria: Colorectal cancer patients undergoing elective cytoreductive surgery and HIPEC (20-70 yrs old) American Society of Anesthesiologists physical status I, II, III Exclusion Criteria: Patients under 20 years old. Patients with long-term steroid therapy or immunosuppressive therapy. Patients with long-term NSAIDs therapy. Patients who cannot communicate with other person or with cognitive disorder. Patients who cannot read the consent form.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
TIVA group
Balanced anesthesia group.
In TIVA group, anesthesia will be maintained by propofol and remifentanil infusion under target controlled infusion. Other names: fresofol MCT 1% inj®; Fresenius kabi, Seoul, Korea, Ultian inj®; Hanlim, Seoul, Korea
Anesthesia will be maintained by sevoflurane and remifentanil infusion in the balanced anesthesia group. Other names: Sojourn®, Kyongbo, Seoul, Korea, Ultian inj®; Hanlim, Seoul, Korea,